Nature Reviews Genetics, ISSN 1471-0056, 08/2005, Volume 6, Issue 8, pp. 597 - 610
DNA methylation is a crucial epigenetic modification of the genome that is involved in regulating many cellular processes. These include embryonic development,...
IMPRINTING CONTROL REGION | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CPG-ISLAND METHYLATION | BECKWITH-WIEDEMANN-SYNDROME | GENETICS & HEREDITY | FRAGILE-X-SYNDROME | FACIAL ANOMALIES SYNDROME | IN-VITRO FERTILIZATION | GROWTH-FACTOR-II | DE-NOVO METHYLATION | PRADER-WILLI-SYNDROME | Genomic Imprinting - genetics | Neoplasms - metabolism | DNA Methylation | Neoplasms - genetics | Humans | Genetic Diseases, Inborn - genetics | Genomic Instability - genetics
IMPRINTING CONTROL REGION | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CPG-ISLAND METHYLATION | BECKWITH-WIEDEMANN-SYNDROME | GENETICS & HEREDITY | FRAGILE-X-SYNDROME | FACIAL ANOMALIES SYNDROME | IN-VITRO FERTILIZATION | GROWTH-FACTOR-II | DE-NOVO METHYLATION | PRADER-WILLI-SYNDROME | Genomic Imprinting - genetics | Neoplasms - metabolism | DNA Methylation | Neoplasms - genetics | Humans | Genetic Diseases, Inborn - genetics | Genomic Instability - genetics
Journal Article
BMC GENOMICS, ISSN 1471-2164, 03/2019, Volume 20, Issue 1, pp. 249 - 11
Background: Epigenetic dysregulation is involved in the etiology and progression of various human diseases. Formalin-fixed paraffin-embedded (FFPE) samples...
EPIGENETIC MECHANISMS | FFPE tissues | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Chromatin extraction | GENETICS & HEREDITY | ChIP-seq | HISTONE MODIFICATIONS | IDENTIFICATION | IMMUNOPRECIPITATION | Microbiological assay | Chromatin | Properties | Methods | Paraffins | Disease | Incubation | Genomics | Crosslinking | Genomes | Paraffin | Tissues | Assaying | Pathology | Etiology | Rehydration | Epigenetics | Archiving | Bioinformatics | Deoxyribonucleic acid--DNA
EPIGENETIC MECHANISMS | FFPE tissues | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Chromatin extraction | GENETICS & HEREDITY | ChIP-seq | HISTONE MODIFICATIONS | IDENTIFICATION | IMMUNOPRECIPITATION | Microbiological assay | Chromatin | Properties | Methods | Paraffins | Disease | Incubation | Genomics | Crosslinking | Genomes | Paraffin | Tissues | Assaying | Pathology | Etiology | Rehydration | Epigenetics | Archiving | Bioinformatics | Deoxyribonucleic acid--DNA
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 2013, Volume 754, pp. 3 - 29
Conference Proceeding
Hepatology, ISSN 0270-9139, 09/2018, Volume 68, Issue 3, pp. 1191 - 1193
Journal Article
Hepatology, ISSN 0270-9139, 07/2019, Volume 70, Issue 1, pp. 51 - 66
Alpha‐1 antitrypsin deficiency (AATD) liver disease is characterized by marked heterogeneity in presentation and progression, despite a common underlying gene...
LUNG | METHYLATION | SIGNATURES | PROGNOSIS | DNA | GENE-EXPRESSION | MODEL | GASTROENTEROLOGY & HEPATOLOGY | Phenotypes | Liver diseases | Immune response | Phenotypic variations | Hepatocellular carcinoma | Genomes | Cirrhosis | Liver cancer | Hepatocytes | Fibrosis | Point mutation | Cell cycle | DNA methylation | Epigenetics | Degeneration | Deoxyribonucleic acid--DNA | Genotypes
LUNG | METHYLATION | SIGNATURES | PROGNOSIS | DNA | GENE-EXPRESSION | MODEL | GASTROENTEROLOGY & HEPATOLOGY | Phenotypes | Liver diseases | Immune response | Phenotypic variations | Hepatocellular carcinoma | Genomes | Cirrhosis | Liver cancer | Hepatocytes | Fibrosis | Point mutation | Cell cycle | DNA methylation | Epigenetics | Degeneration | Deoxyribonucleic acid--DNA | Genotypes
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. LB-235 - LB-235
Journal Article
Journal of Psychiatric Research, ISSN 0022-3956, 10/2019, Volume 117, pp. 45 - 54
Dorsolateral prefrontal cortex (DLPFC) and temporal pole (TP) are brain regions that display abnormalities in bipolar disorder (BD) patients. DNA methylation —...
PERCEPTION | DEPRESSION | METHYLATION | CORTEX | PSYCHIATRY | GENE-EXPRESSION | SCHIZOPHRENIA | FASCICULI | DEFICITS | HYPOMETHYLATION | Epigenetic inheritance | Genomics | DNA | Genetic research | GABA | Bipolar disorder | Genomes | Methylation | Gene expression
PERCEPTION | DEPRESSION | METHYLATION | CORTEX | PSYCHIATRY | GENE-EXPRESSION | SCHIZOPHRENIA | FASCICULI | DEFICITS | HYPOMETHYLATION | Epigenetic inheritance | Genomics | DNA | Genetic research | GABA | Bipolar disorder | Genomes | Methylation | Gene expression
Journal Article
2013, 2013, Advances in Experimental Medicine and Biology, ISBN 9781441999665, Volume 754, 27
The maintenance DNA methyltransferase (DNMT) 1 and the de novo methyltransferases DNMT3A and DNMT3B are all essential for mammalian development. DNA...
Human Genetics | Cancer Research | Oncology | Biomedicine | BASE-EXCISION-REPAIR | PROMOTER HYPERMETHYLATION | ONCOLOGY | GENE O-6-METHYLGUANINE-DNA METHYLTRANSFERASE | EMBRYONIC STEM-CELLS | GENETICS & HEREDITY | SQUAMOUS-CELL CARCINOMA | TUMOR-SUPPRESSOR GENE | MISMATCH REPAIR | ACUTE MYELOID-LEUKEMIA | DE-NOVO METHYLATION | WERNER-SYNDROME PROTEIN | DNA Methylation | Animals | DNA Modification Methylases - metabolism | Neoplasms - genetics | Humans | DNA Damage - genetics | Neoplasms - enzymology | DNA Repair - genetics | Neoplasms - pathology | Index Medicus
Human Genetics | Cancer Research | Oncology | Biomedicine | BASE-EXCISION-REPAIR | PROMOTER HYPERMETHYLATION | ONCOLOGY | GENE O-6-METHYLGUANINE-DNA METHYLTRANSFERASE | EMBRYONIC STEM-CELLS | GENETICS & HEREDITY | SQUAMOUS-CELL CARCINOMA | TUMOR-SUPPRESSOR GENE | MISMATCH REPAIR | ACUTE MYELOID-LEUKEMIA | DE-NOVO METHYLATION | WERNER-SYNDROME PROTEIN | DNA Methylation | Animals | DNA Modification Methylases - metabolism | Neoplasms - genetics | Humans | DNA Damage - genetics | Neoplasms - enzymology | DNA Repair - genetics | Neoplasms - pathology | Index Medicus
Book Chapter
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4344 - 4344
Abstract Introduction: Chronic myelomonocytic leukemia (CMML) is a chronic myeloid malignancy associated with monocytosis, autoimmunity (~30%) & an inherent...
Journal Article
Oncogene, ISSN 0950-9232, 08/2002, Volume 21, Issue 35, pp. 5361 - 5379
Methylation of cytosines within the CpG dinucleotide by DNA methyltransferases is involved in regulating transcription and chromatin structure, controlling the...
Histone methylase | DNA methylation | Histone deacetylase | DNA methyltransferase | Chromatin | Transcriptional repression | DE-NOVO | SATELLITE DNA | MESSENGER-RNA EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECOMBINANT HUMAN DNA | MAMMALIAN DEVELOPMENT | chromatin | histone methylase | histone deacetylase | REPLICATION FOCI | CELL BIOLOGY | transcriptional repression | ONCOLOGY | ICF SYNDROME | CYTOSINE-5 METHYLTRANSFERASE | EMBRYONIC STEM-CELLS | GENETICS & HEREDITY | Humans | Methyltransferases - metabolism | Gene Expression Regulation | Gene Silencing | Histone Deacetylases - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Syndrome | Nuclear Proteins | DNA Helicases | DNA Methylation | Animals | Transcription, Genetic | Adenosine Triphosphatases - genetics | Acetylation | Histones - metabolism | Chromatin - genetics | Disease Models, Animal
Histone methylase | DNA methylation | Histone deacetylase | DNA methyltransferase | Chromatin | Transcriptional repression | DE-NOVO | SATELLITE DNA | MESSENGER-RNA EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECOMBINANT HUMAN DNA | MAMMALIAN DEVELOPMENT | chromatin | histone methylase | histone deacetylase | REPLICATION FOCI | CELL BIOLOGY | transcriptional repression | ONCOLOGY | ICF SYNDROME | CYTOSINE-5 METHYLTRANSFERASE | EMBRYONIC STEM-CELLS | GENETICS & HEREDITY | Humans | Methyltransferases - metabolism | Gene Expression Regulation | Gene Silencing | Histone Deacetylases - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Syndrome | Nuclear Proteins | DNA Helicases | DNA Methylation | Animals | Transcription, Genetic | Adenosine Triphosphatases - genetics | Acetylation | Histones - metabolism | Chromatin - genetics | Disease Models, Animal
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4343 - 4343
Abstract Background : TET2, located on chromosome 4q24, is frequently mutated in the majority of patients with chronic myelomonocytic leukemia (CMML). TET2 has...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3987 - 3987
Abstract Background: We previously demonstrated that putative clinical epidemiologic exposures associated with leukemia risk are prevalent among AML patients,...
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
The addition of sitagliptin to usual care in patients with type 2 diabetes and cardiovascular disease was not associated with any change in the risk of major...
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | GLUCOSE-LOWERING DRUGS | STRATEGIES | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | GLUCOSE-LOWERING DRUGS | STRATEGIES | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article